Linda Vatan
- Immunology top 1%
- Immune cells in cancer 11
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 4
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 5
- Cancer Research top 2%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 4
- Fibroblast Growth Factor Research 2
- Physiology top 5%
- Co-authors
- Weiping ZouIlona KryczekLili ZhaoShuang WeiWojciech SzeligaEnde ZhaoNisha NagarshethDongjun Peng
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesChinaPoland
In The Last Decade
Linda Vatan
23 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 2.4k
- Oncology 2.3k
- Cancer Research 818
- Molecular Biology 1.7k
- Physiology 90
Countries citing papers authored by Linda Vatan
This map shows the geographic impact of Linda Vatan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Vatan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Vatan more than expected).
Fields of papers citing papers by Linda Vatan
This network shows the impact of papers produced by Linda Vatan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Vatan. The network helps show where Linda Vatan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linda Vatan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 40 | |
| 3 | 2024 | 16 | |
| 4 | 2022 | 90 | |
| 5 | 2021 | 131 | |
| 6 | 2021 | 69 | |
| 7 | 2020 | 91 | |
| 8 | 2018 | 326 | |
| 9 | Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regressionbreakdown → | 2018 | 449 |
| 10 | Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumorbreakdown → | 2017 | 579 |
| 11 | 2017 | 19 | |
| 12 | 2016 | 30 | |
| 13 | 2016 | 14 | |
| 14 | 2015 | 213 | |
| 15 | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapybreakdown → | 2015 | 893 |
| 16 | 2014 | 297 | |
| 17 | Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cellsbreakdown → | 2014 | 540 |
| 18 | 2012 | 1 | |
| 19 | 2012 | 122 | |
| 20 | 2012 | 1 |
About Linda Vatan
Linda Vatan is a scholar working on Immunology, Oncology and Genetics, having authored 25 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (11 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (5 papers), Epigenetics and DNA Methylation (4 papers), T-cell and B-cell Immunology (4 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.3k citations) and Cancer Research (818 citations). Linda Vatan has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Weiping Zou, Ilona Kryczek, Lili Zhao, Shuang Wei, Wojciech Szeliga, Ende Zhao, Nisha Nagarsheth, Dongjun Peng, Yali Dou and Rebecca Liu. Their work appears in journals such as The Journal of Immunology, OncoImmunology, Cancer Research, Immunity and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.